McNeill Jonathan Insider Trades & Stock Holdings
McNeill Jonathan, President and COO at Crescent Biopharma, Inc. has 2 Form 4 trades on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($77.23K), net -$77.23K. Latest filing: disposed of 3.84K shares of $CBIO on Sep 18, 2026 at $16.71.
- Trades on file
- 2
- Open-market bought
- $0
- Open-market sold
- $77.23K
- Net open-market
- -$77.23K
- Latest filing
- Sep 18, 2026
All insider trades by McNeill Jonathan
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $CBIO | Sell (Open-market sale) 10b5-1 | 3.84K | $16.71 | $64.15K | President and COO | — | |||||||
| $CBIO | Sell (Open-market sale) 10b5-1 | 731 | $17.90 | $13.08K | President and COO | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks McNeill Jonathan traded
Frequently asked questions
Has McNeill Jonathan been buying or selling stock?
McNeill Jonathan has 0 open-market purchases and 2 open-market sales on file, net -$77.23K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was McNeill Jonathan's latest insider trade?
disposed of 3.84K shares of $CBIO on Sep 18, 2026 at $16.71.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.